Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1078 | Neuroendocrinology | ICEECE2012

The limited screening value of insulin-like growth factor-I as a marker for alterations in body composition in very long term adult survivors of childhood cancer

Blijdorp K. , Heuvel M. Van den , Pieters R. , Lely A. Van der , Neggers S.

Introduction: The clinical relevance of low IGF-I levels, caused by cranial radiotherapy, in adult childhood cancer survivors has not been studied extensively. We evaluated whether IGF-I is a useful marker for altered body composition and growth hormone deficiency in this group.Methods: We analyzed retrospective data from 610 adult childhood cancer survivors, retrieved from the late effects clinic. Median age at diagnosis was 6 years (interquartile range...

ea0029p1175 | Obesity | ICEECE2012

Longitudinal changes in body mass index and body composition among 417 adult survivors of childhood cancer

Blijdorp K. , van den Heuvel M. , Pieters R. , Boot A. , van der Lelij A. , Neggers S.

Introduction: Obesity, represented by high body mass index (BMI), is a major complication after treatment for childhood cancer. High amount of total and visceral fat and low lean body mass are described as more reliable determinants, predicting the development of cardiovascular disease. In this study longitudinal changes of BMI and body composition in adult childhood cancer survivors were evaluated.Methods: Data of 417 adult childhood cancer survivors, w...

ea0029p1372 | Pituitary Clinical | ICEECE2012

Effects of previous GH excess and current medical treatment for acromegaly on cognition

Brummelman P. , Koerts J. , Dullaart R. , van den Berg G. , Tucha O. , Wolffenbuttel B. , van Beek A.

Context: In untreated acromegalic patients, decreased cognitive functioning is reported to be associated with the degree of GH and IGF1 excess. Whether previous GH excess or current medical treatment for acromegaly specifically affects cognition remains unclear.Objective: To compare cognitive functioning in patients who are treated for acromegaly and non-functioning pituitary adenomas (NFA). In addition, we assessed the influence of prolonged medical tre...

ea0026p164 | Neuroendocrinology | ECE2011

Sexual desire in female-to-male transsexual persons

Wierckx K , Van De Peer F , Dedecker D , Van Caenegem E , Elaut E , T'Sjoen G

Objective: The current study aims to describe sexual desire in female-to-male transsexuals post SRS (sex reassignment surgery) using a validated questionnaire. The association between serum androgen levels and the intensity and frequency of sexual desire are examined. The data are compared to those of male-to-female transsexual persons.Design: Cross sectional study.Methods: Female-to-male transsexual persons, post SRS, (n=48...

ea0026p563 | Cardiovascular endocrinology and lipid metabolism | ECE2011

Determinants and outcome of amiodarone-associated thyroid dysfunction

Ahmed S , Van Gelder I C , Wiesfeld A C P , Van Veldhuisen D J , Links T P

Background: Amiodarone is frequently associated with thyroid dysfunction. Identifying predictors for amiodarone-associated thyroid dysfunction and assessing treatment outcome may aid clinicians in daily practice.Patients and methods: In our retrospective study, we included 303 consecutive patients with amiodarone therapy for cardiac arrhythmias (260 with atrial fibrillation and 43 with ventricular arrhythmias). Thyroid function tests were performed every...

ea0022p95 | Bone/Calcium | ECE2010

Cross-validated calculation procedure to assess the cholecalciferol loading dose for rapid correction of vitamin D deficiency

van Groningen Lenneke , van Sorge Adriaan , Telting Darryl , Giessen Astrid , de Boer Hans

Introduction: Vitamin D deficiency is very common in Northern Europe. Recently, we developed an equation to calculate the vitamin D deficit, based on the serum 25-OH vitamin D3 (25OHD3) level and body weight: vitamin D deficit (IU)=40×(75−serum 25OHD3)×body weight. The calculated deficit gives the amount of cholecalciferol that is required to raise the serum 25OHD3 level to the target of 75 nmol/l.<p class="abstex...

ea0020p250 | Bone/Calcium | ECE2009

Colecalciferol loading dose guideline for vitamin D deficient adults

van Groningen Lenneke , van Sorge Adriaan , Telting Darryl , Giesen Astrid , de Boer Hans

Introduction: Severe vitamin D deficiency is very common in northern Europe. It is not limited to the elderly, but occurs in a large variety of subjects. Colecalciferol dosing guidelines for rapid correction of vitamin D deficiency are not available.Objective: To assess the optimal Colecalciferol dose regimen, based on body weight, for rapid correction of vitamin D deficiency, in a variety of subjects.Materials and methods: One hun...

ea0014s10.1 | GH and prolactin at their targets | ECE2007

Cellular control mechanisms for GH sensitivity

Strous Ger , van Kerkhof Peter , van den Eijnden Monique , Putters Joyce

The growth hormone (GH) receptor is a key regulator of cellular metabolism. Using model cell systems we have investigated how GH-induced signaling is regulated, both in paracrine and autocrine conditions.Three features render GHR unique: (a) an active ubiquitination system is required for both endocytosis and degradation in lysosomes; (b) uptake of receptor is a continuous process, independent of GH binding and Jak2 signal transduction; (c) only cell sur...

ea0014p128 | (1) | ECE2007

Expression of the neuropeptide cortistatin in haematological malignancies

Dalm Virgil , Staal Frank , Hofland Leo , van der Lely Aart-Jan , van Hagen Martin

Introduction: Cortistatin (CST) is a 17 amino-acid neuropeptide involved in sleep regulation. Due to its structural resemblance to somatostatin (SS), CST binds with high affinity to the 5 known SS receptors. CST also binds to the putative MrgX2 receptor. Previously we demonstrated that various types of human immune cells and tissues as well as lymphoid cell lines express CST mRNA. We suggested that CST plays a regulatory role in immune cell function both in physiological and p...

ea0071023 | Changes in adipocytokines and myokine expression during weight loss in subjects with obesity | BES2020

Changes in adipocytokines and myokine expression during weight loss in subjects with obesity

Frederique Van de Velde , Margriet Ouwens , Arsene-Helene Batens , Yves Van Nieuwenhove , Bruno Lapauw

Background and aim: Adipose and muscle tissue dysfunction are associated with obesity-related complications, especially insulin resistance (IR) and inflammation, which improve after weight loss. The underlying mechanisms are however not yet fully understood. This study investigates changes in systemic and regional markers of IR and inflammation during weight loss in subjects with obesity.Materials and methods: Twenty subjects with obesity (age 49±10...